
Orphazyme A/S ORPH
Orphazyme A/S Betriebszyklus | ORPH
Betriebszyklus Jährlich Orphazyme A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.969 | 117 | 104 | 83.5 | 111 | 113 | 135 | 99.4 | - | 100 | 64 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 135 | 0.969 | 92.8 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Windtree Therapeutics
WINT
|
164 | - | - | $ 26.8 M | ||
|
SQZ Biotechnologies Company
SQZ
|
25.5 | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
392 | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
6.22 | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B | ||
|
AbbVie
ABBV
|
350 | $ 291.22 | 1.06 % | $ 515 B | ||
|
22nd Century Group
XXII
|
169 | $ 1.56 | -19.17 % | $ 287 K | ||
|
Axon Enterprise
AXON
|
98.8 | $ 313.68 | -18.01 % | $ 24.5 B | ||
|
Biogen
BIIB
|
402 | $ 248.51 | 1.88 % | $ 36.4 B | ||
|
Theratechnologies
THTX
|
456 | - | - | $ 83.9 M | ||
|
Exelixis
EXEL
|
140 | $ 69.55 | 1.22 % | $ 18.9 B | ||
|
Gilead Sciences
GILD
|
160 | $ 166.9 | -0.4 % | $ 208 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.46 | -0.12 % | $ 5.75 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
86.7 | $ 155.97 | -0.44 % | $ 20.4 B | ||
|
Insmed Incorporated
INSM
|
400 | $ 114.55 | 5.32 % | $ 22.8 B | ||
|
Johnson & Johnson
JNJ
|
223 | $ 274.89 | 0.95 % | $ 662 B | ||
|
Titan Pharmaceuticals
TTNP
|
81.3 | - | -3.76 % | $ 3.47 M | ||
|
Lineage Cell Therapeutics
LCTX
|
19.2 | $ 1.02 | 3.75 % | $ 235 M | ||
|
Longeveron
LGVN
|
28.6 | $ 1.82 | 6.43 % | $ 32 B | ||
|
Crinetics Pharmaceuticals
CRNX
|
554 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Mesoblast Limited
MESO
|
0.01 | $ 14.26 | 1.13 % | $ 17.2 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
19.1 K | - | -15.15 % | $ 60.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
263 | - | - | $ 521 M | ||
|
Codexis
CDXS
|
70.7 | $ 1.09 | 6.37 % | $ 95 M | ||
|
MannKind Corporation
MNKD
|
457 | $ 3.91 | 4.0 % | $ 1.2 B |